Pfizer: Patient Investors Will Be Rewarded (NYSE:PFE)
· seekingalpha.com
Pfizer remains undervalued, demonstrating robust profitability and offering an attractive forward dividend yield above 6%. Read more on PFE stock here.
JR Research is an opportunistic investor. I was recognized by TipRanks as a Top Analyst, and also by Seeking Alpha as a "Top Analyst To Follow" for Technology, ...